Unituxin 3.5 mg/mL
DINUTUXIMAB · INJECTION · United Therapeutics Corporation
No Recall History
Plain English
Unituxin is a injection containing dinutuximab at 3.5 mg/mL, taken intravenous. Manufactured by United Therapeutics Corporation.
Key Facts
- Brand Name
- Unituxin
- Generic Name
- DINUTUXIMAB
- NDC Code (Product)
66302-014- Manufacturer
- United Therapeutics Corporation
- Strength
- 3.5 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125516
- Drug Class
- Glycolipid Disialoganglioside-directed Antibody [EPC]
- Marketing Start
- 03/10/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is Unituxin used for?
Unituxin contains DINUTUXIMAB. It is a injection taken intravenous. Consult your doctor for specific uses.
Is Unituxin a controlled substance?
Unituxin is not classified as a controlled substance by the DEA.
What is the generic name for Unituxin?
The generic name for Unituxin is DINUTUXIMAB. There are no other listed brand versions of DINUTUXIMAB.
What is the NDC code for Unituxin 3.5 mg/mL?
The NDC (National Drug Code) for Unituxin 3.5 mg/mL is 66302-014, listed by United Therapeutics Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)